CLINICAL FEATURES OF HUMAN HERPESVIRUS 6 INFECTION IN IMMUNOCOMPETENT AND IMMUNOCOMPROMISED PATIENTS: A COMPARATIVE REVIEW
Immunology and Allergology: Science and Practice · 24.07.2026 · (2) · 5-13
DOI: 10.37321/immunology.2026.2-01 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology and Allergology: Science and Practice, online erschienen am 24.07.2026. Verfasst von Andriy Bondarenko und 2 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ось точний текст із наданих зображень для зручного копіювання: CLINICAL FEATURES OF HUMAN HERPESVIRUS 6 INFECTION IN IMMUNOCOMPETENT AND IMMUNOCOMPROMISED PATIENTS: A COMPARATIVE REVIEW Bondarenko A.V.1, ORCID: https://orcid.org/0000-0002-2303-8525 Katsapov D.V.1, ORCID: https://orcid.org/0000-0001-9581-2009 Bondarenko O.V.2, ORCID: https://orcid.org/0000-0003-1755-925X 1Kharkiv national medical university, Kharkiv, Ukraine 2Kharkiv international medical university, Kharkiv, Ukraine Abstract.
Introduction
Human herpesvirus 6 (HHV-6) is a ubiquitous beta-herpesvirus that infects nearly the entire human population during early childhood. Following primary infection, the virus establishes lifelong latency within host immune cells. While HHV-6 infection in immunocompetent individuals is typically benign and self-limiting, viral reactivation in immunocompromised patients may result in severe multisystem and potentially fatal complications.
Objective
To provide a comprehensive comparative analysis of the clinical manifestations, pathogenesis, diagnostic challenges, and therapeutic approaches to HHV-6 infection in immunocompetent and immunocompromised patients. Materials and methods. A review of the medical literature indexed in PubMed, Scopus, and Web of Science from 2000 to 2025 was conducted. Particular emphasis was placed on clinical studies, systematic reviews, cohort analyses, and expert consensus documents addressing HHV-6 infection in patients with different immune statuses.
Results
In immunocompetent hosts, HHV-6 infection predominantly manifests as exanthema subitum in early childhood and is usually associated with a favourable prognosis. In contrast, immunocompromised patients, particularly hematopoietic stem cell and solid organ transplant recipients, frequently experience HHV-6 reactivation associated with encephalitis, pneumonitis, hepatitis, bone marrow suppression, and increased mortality. Diagnostic interpretation is complicated by chromosomally integrated HHV-6 (ciHHV-6), which may mimic active viral infection.
Conclusions
HHV-6 demonstrates dual clinical behaviour determined primarily by the host immune status. Accurate interpretation of molecular diagnostic findings and early recognition of clinically significant viral reactivation are essential for optimizing outcomes in high-risk patient populations.
Zitieren
APA
Bondarenko, A., Katsapov, D., & Bondarenko, O. (2026). CLINICAL FEATURES OF HUMAN HERPESVIRUS 6 INFECTION IN IMMUNOCOMPETENT AND IMMUNOCOMPROMISED PATIENTS: A COMPARATIVE REVIEW. Immunology and Allergology: Science and Practice, 5-13. https://doi.org/10.37321/immunology.2026.2-01
Vancouver
Bondarenko A, Katsapov D, Bondarenko O. CLINICAL FEATURES OF HUMAN HERPESVIRUS 6 INFECTION IN IMMUNOCOMPETENT AND IMMUNOCOMPROMISED PATIENTS: A COMPARATIVE REVIEW. Immunology and Allergology: Science and Practice. 2026:5-13. doi:10.37321/immunology.2026.2-01
BibTeX
@article{Bondarenko2026,
author = {Bondarenko, Andriy and Katsapov, Dmytro and Bondarenko, Olena},
title = {CLINICAL FEATURES OF HUMAN HERPESVIRUS 6 INFECTION IN IMMUNOCOMPETENT AND IMMUNOCOMPROMISED PATIENTS: A COMPARATIVE REVIEW},
journal = {Immunology and Allergology: Science and Practice},
year = {2026},
number = {2},
pages = {5--13},
doi = {10.37321/immunology.2026.2-01}
}
EUVIMED